PRINCETON, N.J., Nov. 30, 2011 /PRNewswire/ -- IntegriChain, Inc., a commercial insight provider supporting the pharmaceutical industry was identified by Forbes as #19 on the list of America's Most Promising Companies. IntegriChain offers 3-5 year subscription based services to help customers improve order forecasting, order monitoring, better manage their sales and marketing activates, and production planning. IntegriChain has grown 60% over the past three years and plans on continuing to do so over the next 3-4, achieving 70-75% of the market share on data coverage across all of US life science.
"We are truly in some rarified air on this list," said IntegriChain CEO Kevin Leininger. "I am thrilled that we have been selected." Leininger was selected to participate in Forbes' VIP Entrepreneurs and Celebrity Mentor round table discussion and one-on-one consultation, the video of which can be found on Forbes.com.
Forbes' list of America's Most Promising Companies features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers, strategic partners and precious investment capital.
"Sizing up younger, privately held companies is hard: Their fortunes can change very quickly and there's a dearth of public data," says Forbes Executive Editor Brett Nelson. "We took a more comprehensive approach to evaluate their health and potential."
To sharpen its search, Forbes teamed up with CB Insights, a Manhattan-based data firm that tracks investment in high-growth private companies. With $650,000 in grants from the National Science Foundation, CB has developed complex software called Mosaic that mines myriad online sources (from press releases and social networks to job boards and court filings) to come up with one, algorithmically derived score that measures a private company's health. Forbes married Mosaic's data-crunching with old-fashioned reporting to assemble a list of rising stars with bright growth prospects. To view the complete the list, please visit www.forbes.com/ampc.
About IntegriChain, Inc. is a next-generation life sciences informatics company. IntegriChain's industry leading platform for channel data integration and enrichment delivers pharmaceutical and biotech manufacturers marketplace insight with unprecedented speed and transparency. Located in Princeton, New Jersey, IntegriChain is a recent recipient of the Inc 500, Red Herring 100 and New Jersey Technology Council's Early Stage Company of the Year.
|SOURCE IntegriChain, Inc.|
Copyright©2010 PR Newswire.
All rights reserved